In an effort to address some of the key concerns for investors surrounding cannabis we will:
Read more >
· Examine recent legislative developments in a number of countries, most importantly Canada and the United States and the subsequent growth in demand.
· Define key terms and important distinctions between medical and recreational cannabis.
· Focus on the legalization of medical cannabis in a growing number of jurisdictions which has led pharmaceutical companies to invest in cannabis-based medicines, as well as alternatives based on synthetically produced cannabinoids.
· Chart the growth of business opportunities across the full spectrum of the cannabis industry – both medical and recreational – including the tentative entry of big players into the market.
Enhanced investor due diligence is required to address the legal, operational, financial and reputational risks the industry is facing – largely as a result of regulatory uncertainties and inconsistencies. We will examine some of the pitfalls of an industry in its infancy.